We are live on ! Find out more
EXE.A

EXTENDICARE INC SUB VTG SHS
EXE.A

Delisted

EXE.A was delisted on the 9th of November, 2006.

0 hedge funds and large institutions have $0 invested in EXTENDICARE INC SUB VTG SHS in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 10 (-1)

100% less capital invested

Capital invested by funds: $1.55M → $0 (-$1.55M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
Holders Change
-1
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$1.55M
Name Holding Trade Value Shares
Change
Change in
Stake
VAM
1
Visium Asset Management
New York
-$1.55M -235,813 Closed

EXE.A Hedge Fund Activity: Q4 2013 in Review

0 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in EXTENDICARE INC SUB VTG SHS (EXE.A) for Q4 2013, worth a combined $0 — down 100% from $1.55M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of EXE.A and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Visium Asset Management, exiting entirely with an estimated $1.55M sold.

  • 0 institutional investors held EXTENDICARE INC SUB VTG SHS (EXE.A) as of Q4 2013, down from 1 in Q3 2013.
  • Funds reported $0 of EXTENDICARE INC SUB VTG SHS stock for Q4 2013, down 100% quarter-over-quarter.
  • 0 funds opened new EXTENDICARE INC SUB VTG SHS positions in Q4 2013 and 1 closed out, a net change of -1 holder.
  • The largest EXTENDICARE INC SUB VTG SHS seller in Q4 2013 was Visium Asset Management, an estimated $1.55M sold.

Based on aggregated 13F filings for Q4 2013.